Catalyst Wire Dossier Catalyst Wire Dossier

ABT-199 (venetoclax)

venetoclax · AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABT-199 (venetoclax), covering 2025-06-10 to 2025-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG) [Phase 2]

See pricing